How to impress a CRA with a PSV at San Jose Clinical Trials

👀 What does it take to be an Assessor for GCSA Clinical Research Site Certification? 👀 Read this short blog to get an insight into the work of our expert assessment team and what it takes to assess clinical trial sites for this fast-growing international standard... 📋👨⚕️👩⚕️🏥 https://lnkd.in/ess8jx5t IAOCR - International Accrediting Organization for Clinical Research GCSA - The Global Quality Standard for Clinical Research Sites #clinicaltrials #clinicalresearch #qualityassured #QA #bestpractice #Certification #accreditation

⚠️ Even experienced study teams still face delays with CTIS Part II submissions. From what I’ve seen in multi-country studies, three pitfalls come up again and again: 1️⃣ Country-specific expectations While CTIS provides a harmonised framework, each country still applies it slightly differently — and unexpected local requests can slow things down if not anticipated early. 2️⃣ Sponsor–CRO coordination Responsibility for submission may sit with one party, while key documents are managed by the other. Unless roles are clear and timelines aligned, this back-and-forth easily causes delays. 3️⃣ Site documentation Sites do collaborate, but CROs must secure local documents on time and adapt the approach to each study’s strategy to avoid bottlenecks. ⏱️ When timelines are tight, these details can make the difference between on-time activation… or weeks of delay. 👉 Curious – what’s been the biggest CTIS Part II challenge you’ve encountered? #CTIS #ClinicalTrials #StudyStartup #ClinicalOperations #Regulatory #EUCTR

𝗧𝗵𝗿𝗲𝗲 FDA inspections.  𝗭𝗲𝗿𝗼 findings. Over the past two years, Science 37 has achieved three consecutive successful FDA inspections, reaffirming the quality, consistency, and compliance of our 𝗗𝗶𝗿𝗲𝗰𝘁-𝘁𝗼-𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗦𝗶𝘁𝗲 across multiple pivotal Phase 3 studies. For study sponsors, this track record means confidence—knowing that every study conducted with Science 37 meets the highest regulatory standards while maintaining the speed, accessibility, and patient-centric approach that our model enables. By combining rigorous investigator oversight, research-grade nursing, 50-state medical licensure, CRC support, and direct-to-patient logistics, our site continues to deliver high-quality, regulatory-compliant data, helping sponsors facilitate faster enrollment and enhance trial accessibility. 🔗 Read more about our latest FDA inspection: https://lnkd.in/eXkqr8ba

Tips in trials: Initials and signatures in clinical trials: We know surname alone is not a valid signature and that it applies to both paper and electronic signatures in clinical trials. But how about sites? I am still reviewing signatures on consent forms as a CRA. Again, some findings are the same - initials and surnames. Are initials signatures? No Are only surnames signatures? No It is so easy to say, but it is not easy to become a standard at sites. That`s why I talk about Basic First - to prevent common mistakes like this, reduce corrections, and save time & money. It really seems very easy, but try to explain it at sites and you will see that for some adaptions it takes time. It is very important sites to hear that and that someone tells them in a way it stays in mind. Have you seen that in your practice? What inspection said? How do you explain that? Share your thoughts, or example. #sitecentricapproach #sitemanagement #clinicaltrials

🌀 IMVs can be chaotic... Matching paper CRFs to hospital records, to lab reports, to clinic notes, to EDC entries, etc... when all can be considered source! It’s no wonder that monitoring visits often take longer than expected, leaving sponsors and sites frustrated, and costing everyone more time and money. To help CRAs streamline this process, Ochabski Consulting has developed a Source Matching Template for IMVs. This checklist makes it easier to: ✅ Track subject IDs, visits, and associated forms ✅ Reference source document types and locations ✅ Verify data points with match/mismatch fields ✅ Capture discrepancies and comments for accountability Why use it? - Improve data accuracy & integrity - Support compliance with GCP & regulatory requirements - Save time, reduce costs, and protect participant safety If you’d like a copy of the template, email OchabskiConsulting@gmail.com to request it. #ClinicalResearch #CRA #Monitoring #ClinicalTrials #GCP #DataIntegrity

🔬 ✨ Thursday Thoughts | Lori’s Clinical Corner “The Power of a 5-Minute Recheck” After years supporting clinical trials across pharma and CRO environments, one truth has never changed: A 5-minute recheck can save a 5-week delay. Details matter, they protect patients, timelines, and reputations. It’s just how I work, I like to be sure things are right before moving on. Whether it’s verifying budgets, preparing study documents, or supporting site start-up, accuracy builds trust, and that’s something I bring to every study I touch. Because in this work, small details add up to something big. #ThursdayThoughts #ClinicalResearch #ClinicalOperations #CTA #StudyStartUp #AttentionToDetail #JobSearch

Certified Medical Consultants (CMC) coordinates thousands of Independent Medical Examinations (IMEs) each month, partnering with credentialed physicians who are part of the CMC panel. Upon receiving medical records from clients, CMC meticulously organizes the documentation and forwards relevant questions to the examining physician to ensure all concerns are thoroughly addressed. Once the physician completes the draft report, it is returned to CMC for a rigorous quality assurance process, guaranteeing accuracy, clarity, and completeness before final delivery.

🔍 Understanding Types of Monitoring Visits in Clinical Research 💊✨ In clinical trials, monitoring visits are crucial to ensure data quality, participant safety, and compliance with GCP and protocol requirements. Each visit has a distinct purpose that contributes to the overall success of the study. Here’s a quick overview 👇 1️⃣ Site Qualification Visit (SQV) 🏥 The first step before study initiation — to assess if the site has adequate facilities, equipment, and qualified staff to conduct the trial successfully. 2️⃣ Site Initiation Visit (SIV) 🚀 Once the site is selected, this visit trains the team on the protocol, study procedures, CRF/eCRF entry, IP handling, and documentation standards. It ensures the site is ready to begin enrolling participants. 3️⃣ Interim Monitoring Visit (IMV) 🔄 Conducted periodically after the study starts. The CRA verifies informed consent forms, source data, safety reporting, and overall compliance. It’s the core phase for continuous oversight and data validation. 4️⃣ Close-Out Visit (COV) �� The final visit after all subjects complete the study. Ensures all data queries are resolved, IP is accounted for, essential documents are archived, and the site is inspection-ready. Each visit plays a vital role in maintaining data integrity, protocol adherence, and patient safety — the three pillars of every successful clinical trial. 💬 Monitoring is not just about checking data — it’s about ensuring that research translates into reliable, ethical, and impactful science. #ClinicalResearch #MonitoringVisits #CRA #CTA #GCP #ClinicalTrials #DrugDevelopment #ResearchIntegrity

✈️ Behind Every Site Visit, There's a Story. As I reflect on my journey through clinical research, I’m reminded of the many roles that have shaped my perspective, and one of the most formative ones was my time as a CRA. CRAs are the powerhouse that keeps clinical research running! From monitoring data integrity to ensuring patient safety and protocol compliance, CRAs are the bridge between sponsors, CROs, and the sites where real patients put their trust in science. Yes, CRAs write reports. Yes, CRAs catch deviations. But there’s so much more behind the scenes: ✅ Red-eye flights and 5 a.m. alarms. ✅ Hours spent reviewing charts in cramped site offices. ✅ Balancing precision, timelines, and human connection. ✅ Advocating for site staff who are overwhelmed, and ensuring every subject is protected. ✅ Being the eyes and ears on the ground, often the first to spot trends, risks, or issues long before they escalate. CRAs are more than just monitors, they are navigators, auditors, collaborators, and protectors of the trial process. Even in my current role today, there are still days where I find myself thinking (and often speaking) like a CRA. Because once a CRA, you’re always a CRA. That mindset never leaves you: the eye for detail, the urgency to act, the empathy for site staff, and the drive to protect patients and data alike. The role is often underappreciated, especially when the focus by many sponsors is on what was “missed,” but rarely do we stop to acknowledge what was caught, supported, and prevented because a CRA was there, doing the work. Here’s to the CRAs—the unsung heroes who keep trials moving forward. #ClinicalResearch #CRA #GCPCompliance #ClinicalOperations #LifeSciences #MonitoringMatters #ClinicalTrials

🔍 Source Data Verification (SDV) in Clinical Research Source Data Verification (SDV) is a critical step in ensuring data accuracy and reliability in clinical trials. It involves comparing the data recorded in the Case Report Form (CRF) with the original source documents such as hospital records, lab reports, or patient charts. As a Clinical Research Coordinator, I’ve learned that effective SDV helps ensure data integrity and compliance with GCP guidelines. It also plays a key role in maintaining the credibility of study results. ✅ Key points I focus on during SDV: Accuracy of entered data Completeness of source documentation Timely query resolution Maintaining confidentiality and compliance Continuous learning in SDV strengthens our role in ensuring quality clinical trial outcomes. #clinicalresearch #imedidata #signanthealth #eCRF #paperCRF #clinicalresearchcoordinator